Recent Events & Catalysts
Rhythm Pharmaceuticals, Inc. (RYTM) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
JP Morgan Maintains Overweight on Rhythm Pharmaceuticals, Raises Price Target to $146
Benzinga · 4d ago
Citigroup Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $143
Benzinga · 6d ago
RBC Capital Maintains Outperform on Rhythm Pharmaceuticals, Raises Price Target to $155
Benzinga · 6d ago
Citizens Maintains Market Outperform on Rhythm Pharmaceuticals, Raises Price Target to $160
Benzinga · 6d ago
Rhythm Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlpha · 6d ago
Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2026 Earnings Call Transcript
SeekingAlpha · 7d ago
Full Transcript: Rhythm Pharmaceuticals Q2 2026 Earnings Call
Benzinga · 7d ago
Rhythm Pharmaceuticals Q2 EPS $(0.73) Beats $(0.82) Estimate, Sales $71.255M Beat $67.277M Estimate
Benzinga · 7d ago
SEC Filings (90 days)
Results of operations (earnings release), Regulation FD disclosure, Other events, Financial statements and exhibits
Filed 2026-08-04 · 7d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-25 · 47d ago
Regulation FD disclosure, Other events, Financial statements and exhibits
Filed 2026-06-15 · 57d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.